sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Ivermectin Medication Market Scope And Analysis

  • Report Code : TIPRE00013506
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato dei farmaci a base di ivermectina e dei concorrenti entro il 2025-2031

Buy Now

Ivermectin Medication Market Report Ivermectin Medication Market Size and Share Ivermectin Medication Market Scope and Analysis

Ivermectin Medication Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Via di somministrazione
  • orale
  • iniettore
By Indicazione
  • Oncocercosi
  • Ascariasis
  • Strongiloidosi
  • Malattia parassitaria intestinale
  • Filariasi linfatica
  • Altri
By Applicazione
  • uso umano
  • uso veterinario
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Novartis AG
  • Intas Pharmaceuticals
  • Boehringer Ingelheim International GmbH
  • Cipla, Inc.
  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Bayer AG